Ionis Pharmaceuticals (IONS) is up 31.2%, or $13.28 to $55.92.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IONS:
- Ionis Pharmaceuticals’ Olezarsen Triumphs in Phase 3 Trials, Analyst Raises Price Target
- Ionis Pharmaceuticals rises 26.5%
- Ionis Pharmaceuticals price target raised to $96 from $83 at Jefferies
- Ionis Pharmaceuticals price target raised to $95 from $70 at H.C. Wainwright
- Ionis Pharmaceuticals’ Olezarsen Shows Promising Phase III Results in Reducing Triglycerides and Pancreatitis Risk